Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samsung Biologics | Seoul | Healthcare | Pharmaceuticals | ₩70.53T | 69.1x | 2.6 | ₩1,000,000 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30% Upside | Upgrade to Pro+ | |
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩32.36T | 81.7x | -1.75 | ₩154,300 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alteogen | KOSDAQ | Healthcare | Pharmaceuticals | ₩17.91T | 315.6x | 0.16 | ₩348,000 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩7.86T | 126.9x | -2.36 | ₩107,800 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩7.86T | 126.9x | -2.36 | ₩99,400 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩7.46T | -74.7x | -1.51 | ₩57,100 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sk Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩6.93T | 33.2x | 0.04 | ₩92,000 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Classys Inc | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩4.22T | 42.1x | 1.52 | ₩65,400 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.8% Upside | Upgrade to Pro+ | |
Pharma Reaserch Products | KOSDAQ | Healthcare | Pharmaceuticals | ₩4.14T | 37.5x | 2.33 | ₩398,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -14.6% Downside | Upgrade to Pro+ | |
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.98T | -82.7x | 4.74 | ₩194,600 | 13.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hugel | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.69T | 27.8x | 0.55 | ₩344,000 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.52T | 487x | 4.23 | ₩99,700 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hanmi Pharm Co | Seoul | Healthcare | Pharmaceuticals | ₩3.42T | 25.3x | -1.67 | ₩277,000 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30% Upside | Upgrade to Pro+ | |
Sam Chun Dang Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.17T | -308.7x | ₩148,000 | 8.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
SK Bioscience Co | Seoul | Healthcare | Pharmaceuticals | ₩3.1T | -56.5x | 0.17 | ₩40,000 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.7% Upside | Upgrade to Pro+ | |
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.9T | -29.1x | 0.03 | ₩61,700 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34% Upside | Upgrade to Pro+ | |
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.86T | ₩32,500 | -7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Celltrion Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩2.03T | 90.9x | ₩47,000 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Hanmi Science | Seoul | Healthcare | Pharmaceuticals | ₩2.01T | 32x | -0.7 | ₩30,950 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.67T | -51.9x | -2.31 | ₩99,400 | 6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nature Cell | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.63T | 1,587.1x | 12.44 | ₩24,550 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daewoong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.55T | 65.4x | -0.82 | ₩136,900 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lunit | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩1.52T | -15.1x | 0.18 | ₩54,400 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.7% Upside | Upgrade to Pro+ | |
Caregen | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.49T | 39.5x | -1.87 | ₩31,250 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.4% Upside | Upgrade to Pro+ | |
ST Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.44T | 43.1x | 0.61 | ₩73,600 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GC Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.35T | -51.3x | -39.15 | ₩119,900 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hanall Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.33T | -802.2x | 4.91 | ₩27,000 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.25T | -53.6x | 0.02 | ₩29,500 | 8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.5% Upside | Upgrade to Pro+ | |
HK Inno.N | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.14T | 25x | ₩40,750 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Mezzion Pharma | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.1T | -51.5x | 1.31 | ₩37,100 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SD Biosensor | Seoul | Healthcare | Healthcare Equipment & Supplies | ₩1.09T | -10.4x | -0.14 | ₩9,500 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medy-Tox | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.06T | 68.8x | 0.92 | ₩164,000 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.2% Upside | Upgrade to Pro+ | |
Chong Kun Dang Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.04T | 9.6x | -0.21 | ₩80,500 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oscotec | KOSDAQ | Healthcare | Pharmaceuticals | ₩973.42B | 1,245.7x | 11.18 | ₩26,500 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩871.23B | ₩15,200 | 7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩846.38B | -20x | 0.26 | ₩43,700 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daewoong | Seoul | Healthcare | Pharmaceuticals | ₩830.08B | 13.6x | -0.23 | ₩19,810 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.9% Upside | Upgrade to Pro+ | |
Won Tech Co | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩802.24B | 24.1x | -1.09 | ₩8,890 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -26.5% Downside | Upgrade to Pro+ | |
HLB Life Science | KOSDAQ | Healthcare | Pharmaceuticals | ₩779.69B | 112.4x | 0.67 | ₩6,440 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boryung Pharm | Seoul | Healthcare | Pharmaceuticals | ₩703.53B | 8.4x | 0.15 | ₩8,530 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dongkook Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | ₩694.29B | 10.7x | 0.38 | ₩15,680 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.1% Upside | Upgrade to Pro+ | |
Pharmicell | Seoul | Healthcare | Pharmaceuticals | ₩658.24B | -18.6x | ₩11,420 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
HLB Therapeutics | KOSDAQ | Healthcare | Pharmaceuticals | ₩655.63B | -30.4x | 0.04 | ₩7,830 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Donga Socio Holdings | Seoul | Healthcare | Pharmaceuticals | ₩645.46B | 10.9x | ₩100,700 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.4% Upside | Upgrade to Pro+ | ||
Green Cross | Seoul | Healthcare | Pharmaceuticals | ₩622.35B | 24.1x | 0.18 | ₩13,690 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross Holdings | Seoul | Healthcare | Pharmaceuticals | ₩622.35B | 24.1x | 0.18 | ₩20,450 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chabiotech | KOSDAQ | Healthcare | Healthcare Providers & Services | ₩588.28B | -65.2x | -18.01 | ₩10,320 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
T And L | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩573.11B | 12.9x | 0.19 | ₩72,900 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.1% Upside | Upgrade to Pro+ | |
Huons Global | KOSDAQ | Healthcare | Pharmaceuticals | ₩565.15B | 21.4x | -0.73 | ₩48,050 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inventage Lab | KOSDAQ | Healthcare | Pharmaceuticals | ₩542.43B | ₩50,300 | -6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |